Acute necrotizing pancreatitis as a fatal complication following DC Bead transcatheter arterial chemoembolization for hepatocellular carcinoma: A case report and review of the literature.

Transcatheter arterial chemoembolization (TACE) is one of the most effective palliative measures for patients with inoperable hepatocellular carcinoma (HCC). Acute pancreatitis is a rare but well-known complication following TACE. We herein present the case of a patient with HCC who developed fatal complications (acute necrotizing pancreatitis and upper gastrointestinal ulcers) after TACE with DC Beads. The patient was diagnosed with HCC in segments 4 and 8, measuring ~70 mm in greatest diameter, and he was treated by TACE. Hepatic arteriography revealed replacement of the origin of the right hepatic artery to the superior mesenteric artery, while the left hepatic artery originated from the celiac artery. After selection of the segmental arterial branches feeding the tumor, 2 ml of 100-300-µm-sized DC Beads loaded with 150 mg epirubicin were injected through the microcatheter. The patient complained of abdominal pain after the TACE procedure. Upper gastrointestinal endoscopy revealed longitudinal ulcers from the esophagus to the duodenum, and contrast-enhanced computed tomography revealed swelling of the pancreas and focal areas of low density in the pancreatic body, suggesting necrosis. The patient developed respiratory insufficiency, renal failure and sepsis, and finally succumbed to the complications 54 days after the procedure, despite general management of the acute pancreatitis. An autopsy revealed that the main cause of the patient's death was extensive pancreatic necrosis due to a gastroduodenal artery embolism after TACE with DC Beads. Therefore, it is crucial for treating physicians to be aware of this complication following TACE with DC Beads, particularly in patients with anatomical variations.

[1]  R. F. Short,et al.  Acute pancreatitis as a complication of trans-arterial chemoembolization of hepatocellular cancer-case report and review of literature. , 2017, Journal of gastrointestinal oncology.

[2]  M. T. Ferrer-Ríos,et al.  Acute necrotizing pancreatitis after transarterial chemoembolization of hepatocellular carcinoma: An unusual complication. , 2014, Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva.

[3]  Myeong Jun Song,et al.  Supraumbilical Subcutaneous Fat Necrosis After Transcatheter Arterial Chemoembolization with Drug-Eluting Beads: Case Report and Review of the Literature , 2013, CardioVascular and Interventional Radiology.

[4]  G. Yagci,et al.  Acute ischemic cholecystitis after transarterial chemoembolization with drug-eluting beads. , 2012, Clinical imaging.

[5]  J. H. Kim,et al.  A case of necrotizing pancreatitis subsequent to transcatheter arterial chemoembolization in a patient with hepatocellular carcinoma , 2012, Clinical and molecular hepatology.

[6]  M. Ilyas,et al.  Chemoembolization of Hepatocellular Carcinoma with Drug-Eluting Beads Complicated by Interstitial Pneumonitis , 2011, Seminars in interventional radiology.

[7]  E. Alexopoulou,et al.  Safety Profile of Sequential Transcatheter Chemoembolization with DC Bead™: Results of 237 Hepatocellular Carcinoma (HCC) Patients , 2011, CardioVascular and Interventional Radiology.

[8]  T. Vogl,et al.  Prospective Randomized Study of Doxorubicin-Eluting-Bead Embolization in the Treatment of Hepatocellular Carcinoma: Results of the PRECISION V Study , 2009, CardioVascular and Interventional Radiology.

[9]  L. Grenacher,et al.  Acute Pancreatitis after Embolization of Liver Tumors: Frequency and Associated Risk Factors , 2007, Pancreatology.

[10]  Ting-KaiLeung,et al.  Anatomic and technical skill factor of gastroduodenal complication in post-transarterial embolization for hepatocellular carcinoma:A retrospective study of 280 cases , 2005 .